Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
53.6%
% of PBE's 28 holdings also in FBT
50.0%
% of FBT's 31 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 5.1% | 4.3% | 4.3% |
|
AMGEN INC | 5.0% | 4.1% | 4.1% |
|
BIOGEN IDEC INC | 5.0% | 3.2% | 3.2% |
|
REGENERON PHARMACEUTICALS | 4.5% | 3.2% | 3.2% |
|
HALOZYME THERAPEUTICS INC | 3.1% | 4.2% | 3.1% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to FBT
|
PROTAGONIST THERAPEUTICS, INC. | 3.9% |
|
TG THERAPEUTICS INC | 3.8% |
|
CATALYST PHARMACEUTICAL PART | 3.3% |
|
PTC THERAPEUTICS INC | 3.0% |
|
COLLEGIUM PHARMACEUTICAL, INC. | 2.9% |
|
DYNAVAX TECHNOLOGIES CORP | 2.9% |
|
BLUEPRINT MEDICINES CORP. | 2.7% |
|
BIOCRYST PHARMACEUTICALS INC | 2.7% |
|
ROYALTY PHARMA PLC CLASS A | 2.6% |
|
BIO-TECHNE CORPORATION | 2.6% |
PBE Underweight Relative to FBT
|
BEIGENE LTD. SPONSORED ADR | -5.2% |
|
INTRA-CELLULAR THERAPIES INC | -4.8% |
|
VERTEX PHARMACEUTICALS INC | -4.2% |
 |
ALKERMES PLC | -4.1% |
|
ALNYLAM PHARMACEUTICALS INC | -3.9% |
|
CORCEPT THERAPEUTICS INC | -3.8% |
 |
METTLER-TOLEDO INTERNATIONAL | -3.4% |
|
WATERS CORP | -3.3% |
 |
GENMAB A/S SPONSORED ADR | -3.1% |
 |
ARGENX SE ADR | -3.1% |